True North Advisors’s Sanofi SNY Stock Holding History

True North Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,394	Closed	-$1.82M	–	232
2023 Q1	$1.82M	Sell	33,394 -16,666	-33%	-$811K	0.53%	43
2022 Q4	$2.42M	Hold	50,060	–	–	0.83%	28
2022 Q3	$1.9M	Hold	50,060	–	–	0.62%	38
2022 Q2	$2.5M	Hold	50,060	–	–	0.78%	30
2022 Q1	$2.57M	Buy	50,060 +9,963	+25%	+$514K	0.69%	33
2021 Q4	$2.01M	Buy	40,097 +10,586	+36%	+$524K	0.34%	67
2021 Q3	$1.42M	Buy	29,511 +8	+0%	+$407	0.28%	83
2021 Q2	$1.55M	Buy	29,503 +1	+0%	+$52	0.32%	70
2021 Q1	$1.46M	Sell	29,502 -15	-0.1%	-$721	0.35%	64
2020 Q4	$1.43M	Sell	29,517 -271	-0.9%	-$13.4K	0.37%	63
2020 Q3	$1.49M	Buy	29,788 +332	+1%	+$17.1K	0.44%	55
2020 Q2	$1.5M	Buy	+29,456	New	+$1.43M	0.36%	60

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

True North Advisors's SNY Position: Q2 2023 in Review

True North Advisors sold out of Sanofi (SNY) in Q2 2023, closing a stake of 33,394 shares — an estimated $1.82M sold.

True North Advisors first reported a position in SNY in Q2 2020 and held it in 12 quarters. The position peaked at $2.57M in Q1 2022. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

True North Advisors reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
True North Advisors sold 33,394 Sanofi shares in Q2 2023, an estimated $1.82M.
True North Advisors first reported a position in Sanofi in Q2 2020 and held it in 12 quarters.
True North Advisors's Sanofi position peaked at $2.57M in Q1 2022.
672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on True North Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.